National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes.

By D. A. Morrow, C. Cannon, R. Jesse, L. Newby, J. Ravkilde, A. Storrow, A. Wu, R. Christenson, F. Apple, G. Francis and 1 more. Clinical Chemistry, 2007

696 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging

View Paper: https://www.semanticscholar.org/paper/12a87f60b10b78b1002a2ecd97aee14fb3d70d49

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. D. A. Morrow
2. Harvey D. White
3. K. Thygesen
4. Joseph S. Alpert
5. M. Drazner

Citations in the corpus

• Universal definition of myocardial infarction. (2007, background): “As with troponin, an increased CKMB value is defined as a measurement above the 99th percentile URL, which is designated as the decision level for the diagnosis of myocardial infarction ( 9 ).”
• Association of Troponin T Detected With a Highly Sensitive Assay and Cardiac Structure and Mortality Risk in the General Population (2010, positive): “C A R D I A C T R O P O N I N S T (cTnT) and I are the preferred biomarkers for the diagnosis of acute myocardial infarction (MI).(1,2) Increasingly it has been recognized that elevated troponin levels may be detected in other clinical scenarios in which acute myocardial injury may occur(3,4) as wel”